BrahMos WORLD INDIA MADHYA PRADESH BHOPAL WTN SPECIAL GOSSIP CORNER RELIGION SPORTS BUSINESS FUN FACTS ENTERTAINMENT LIFESTYLE TRAVEL ART & LITERATURE SCIENCE & TECHNOLOGY HEALTH EDUCATION DIASPORA OPINION & INTERVIEW RECIPES DRINKS BIG MEMSAAB 2017 BUDGET 2017 FUNNY VIDEOS VIRAL ON WEB PICTURE STORIES Mahakal Ke Darshan
WTN HINDI ABOUT US PRIVACY POLICY SITEMAP CONTACT US
logo
Breaking News

Gastric medications may up risk for bacterial infection

Tuesday - March 28, 2017 2:50 pm , Category : DIASPORA
 Gastric medications may up risk for bacterial infection
Gastric medications may up risk for bacterial infection

New York March 28 (IANS) People using gastric acid suppression medications may be at a higher risk of bacterium infection that can cause diseases ranging from diarrhoea to life-threatening colon inflammation researchers including one of Indian-origin warned.

Infections by Clostridium difficile colitis (C-diff) is caused by disruption of normal healthy bacteria in the colon often as a result of antibiotics.

The findings suggest that patients who previously had a case of C-diff and receive gastric acid suppressants may be at increased risk of C-diff recurrence.

The study found that use of gastric acid suppression medications are associated with a statistically significant increased risk of development of recurrent C-diff in patients with a prior episode of C-diff said Sahil Khanna a gastroenterologist at US-based non-profit Mayo Clinic.

For the study published in JAMA Internal Medicine the team conducted a systematic review and meta-analysis of 16 studies with 7 703 patients with C-diff and 1 525 of these developed recurrent C-diff.

The researchers analysed gastric suppression medications including proton pump inhibitors such as omeprazole and histamine 2 blockers such as ranitidine which are commonly prescribed and consumed over-the-counter medications for gastroesophageal reflux disease peptic ulcer disease or dyspepsia.

The results showed that the rate of recurrent C-diff in patients with gastric suppression was 22.1 per cent compared to 17.3 per cent in patients without gastric acid suppression.

Thus it may be reasonable to re-evaluate the need for these medications in patients with C-diff Khanna noted.

--IANS
rt/vgu/dg